...
首页> 外文期刊>Chinese Journal of Contemporary Neurology and Neurosurgery >Analysis on the risk factors for multiple transfusion in patients with moderate or severe traumatic brain injury
【24h】

Analysis on the risk factors for multiple transfusion in patients with moderate or severe traumatic brain injury

机译:中等或严重创伤性脑损伤患者多重输血危险因素分析

获取原文
           

摘要

Abstract Objective To analyze the risk factors for multiple transfusions in patients with moderate or severe traumatic brain injury (TBI). Methods The clinical data of 53 patients undergoing decompressive craniectomy with moderate or severe TBI from January 2018 to June 2019 were analyzed. Coagulation indexes were tested before decompressive craniectomy. The factors associated with multiple transfusions were analyzed by univariate and multivariate Logistic regression analysis. Results Patients were divided into multiple transfusion group (11cases) and control group (42 cases, no transfusion or single transfusion). Thrombin time (P=0.041), international normalized ratio (P=0.048), fibrinogen degradation product (P=0.000) and D?dimer (P=0.001) in the multiple transfusion group were higher than those in the control group, while fibrinogen was lower than those in the control group (P=0.006). Logistic regression analysis showed that fibrinogen degradation product was a risk factor for multiple transfusions (OR=1.013, 95%CI:1.005-1.021; P=0.002). Conclusions Elevated fibrinogen degradation product is a risk factor for multiple transfusions in patients with moderate or severe TBI.
机译:摘要目的分析中度或严重创伤性脑损伤(TBI)患者多重输血的危险因素。方法分析了从2018年1月至2019年6月到2019年6月接受缓解颅骨切除术治疗颅骨切除术的53例患者的临床资料。在减压颅肌切除术前测试凝血指标。通过单变量和多变量逻辑回归分析分析了与多种输血相关的因素。结果患者分为多重输血组(11Case)和对照组(42例,没有输血或单输血)。凝血酶时间(p = 0.041),国际归一化比(P = 0.048),多重输血基团中的纤维蛋白原降解产物(P = 0.000)和Dα二聚体(p = 0.001)高于对照组,而纤维蛋白原低于对照组的那些(p = 0.006)。物流回归分析表明,纤维蛋白原降解产物是多重输血的危险因素(或= 1.013,95%CI:1.005-1.021; p = 0.002)。结论升高的纤维蛋白原降解产物是中度或严重TBI患者多重输血的危险因素。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号